New Cannabis Research from KGK Science Published in Translational Neuroscience
Changing the Tone of Clinical Study Design in the Cannabis Industry The latest cannabis research from KGK Science has been published in the premier research journal, Translational Neuroscience. “Changing the tone of clinical study design in the cannabis industry” focuses on the need for synchronization of the circadian rhythms of study populations when designing clinical studies for […]
KGK Science President & CEO Joins International Probiotics Association Board of Directors
Najla Guthrie, President & CEO of KGK Science, has joined the International Probiotics Association (IPA) Board of Directors, effective April 2020. A global non-profit organization bringing together the probiotic sector’s stakeholders, the IPA’s mission is to promote the safe and efficacious use of probiotics throughout the world. KGK has been actively involved with IPA for […]
KGK Science Named Best Nutraceutical and Cannabinoid Full-Service CRO 2020 By Global Health & Pharma
April 14, 2020 – KGK Science has been recognized by the Global Health & Pharma (GHP) Medical Marijuana Awards as the Best Nutraceutical and Cannabinoid Full-Service CRO 2020. GHP hosts the Medical Marijuana Awards annually to recognize organizations that have facilitated the rise and success of cannabinoid products in the global market. This win speaks to […]
Largest North American Clinical Trial on Probiotic Strains for IBS Symptoms Conducted by KGK Science
May 19, 2020 – The findings from a clinical trial conducted by KGK Science studying the impact of two single strain probiotics on the severity of gastrointestinal symptoms and psychological well-being of individuals with certain IBS subtypes has been published in the peer-reviewed journal of human nutrition, Nutrients. The randomized, double-blind, placebo-controlled study contracted by Lallemand […]
KGK Contracted by Hofseth Biocare for Phase 2 Clinical Trial for Easing COVID-19 Complications in Former Smokers
May 26, 2020 – KGK Science is developing a protocol with Hofseth Biocare for an accelerated phase 2 clinical trial assessing Hofseth’s CARDIO soft gels, a natural salmon oil-based reducer of eosinophil effector function, as a treatment for patients with Acute Respiratory Distress Syndrome (ARDS) caused by the SARS-CoV-2 virus. The clinical trial will examine […]
New Study Finds Relieve-R to be Safe and Effective for Pain Relief
August 28, 2020 – A recent clinical trial conducted by KGK Science has found evidence to support a natural health product, Relieve-R (formerly Pain Bloc-R), having the ability to provide occasional pain relief and reduce inflammation in healthy adults. The 7-day, randomized, double-blind, placebo-controlled, crossover study, sponsored by LifeSeasons Inc., demonstrated statistical significance to reduce occasional […]
KGK Launches Virtual Clinical Trial to Test the Efficacy of a Natural Health Product to Ease Symptoms of COVID-19
September 21, 2020 – A KGK Science clinical trial to investigate the efficacy of a natural health product to ease the symptoms of COVID-19 has launched in major cities across Ontario. The Health Canada approved phase 2 clinical trial sponsored by Hofseth Biocare will examine a natural salmon oil-based supplement, CARDIO soft gels, in combination with […]
KGK Science Issued Health Canada Research License to Conduct Sensory Trials for Cannabis Products
September 22, 2020 – KGK Science (“KGK”) has received its second Cannabis Research License from Health Canada under the Cannabis Act. This latest license issued to KGK permits the administration of cannabis extracts (inhalable and ingestible), edible cannabis, dried flower, and cannabis topicals to human subjects for the purposes of palatability and sensory testing. Utilizing customized […]
KGK Science Contracted by Fluid Energy Group Ltd. for Serious Adverse Reaction Reporting
November 23, 2020 – KGK Science has been contracted by Fluid Energy Group Ltd. to provide Serious Adverse Reaction Reporting services for their Triton™ Life Sciences line of hand sanitizers and surface disinfectants. Under this agreement, KGK will employ its medical and regulatory expertise to assess any adverse reactions reported by consumers across North America to […]
KGK Science Provides Regulatory Path-to-Market Strategy to Psyched Wellness for Functional Mushroom Extract Launch
December 9, 2020 – KGK Science has been contracted by Canadian health supplement company Psyched Wellness to provide a strategic regulatory package of services to support the launch of their novel Amanita muscaria mushroom extract. The services provided by KGK will ensure regulatory compliance for sale of the product in the U.S. and Canada, ultimately helping Psyched Wellness with […]